Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neural restrictive silencer factor,
NRSF
(also known as REST) binds a neuronal cell type selective silencer element to mediate transcriptional repression of neuron-specific genes in non-neuronal cells and neuronal progenitors. Two repression domains (RD-1 and RD-2) occur in its N-terminal and C-terminal regions, respectively. RD-1 recruits mSin3 and HDAC, thereby inhibiting transcription by inducing reorganization of the chromatin structure. However, little is known about how such global repression becomes promoter-specific repression or whether the
NRSF
-HDAC complex can interact with transcriptional core factors at each specific promoter. Here we show evidence that
NRSF
interacts with core promoter factors, including
TATA-binding protein
(
TBP
). The
NRSF
-
TBP
interaction occurred between the linear segments of the N- and C-terminal-most portions of
NRSF
and the C-terminal half of
TBP
. A RD-2 mutant of
NRSF
lost the
TBP
-binding activity and was unable to repress transcription at an exogenously introduced TGTA promoter. These results indicate that the direct interaction between the
NRSF
C-terminal domain and
TBP
is essential for the C-terminal repression mechanism of
NRSF
. Thus, the RD-1 and RD-2 repression domains of
NRSF
utilize both chromatin-dependent and chromatin-independent mechanisms, which may be segregated at various stages of neural development and modulation.
...
PMID:Direct interaction of NRSF with TBP: chromatin reorganization and core promoter repression for neuron-specific gene transcription. 1519 46